drugset / Trial / NCT07324408
Multiple Ascending Dose Study of NH102 in Healthy Subjects
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to assess the safety, tolerability and pharmacokinetics (PK) of NH102 when administered as multiple oral dose at escalating dose levels in healthy participants.
Timeline
- Start
- 2022-03-10
- Primary completion
- 2023-04-10
- Completion
- 2023-04-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | NH102 | Unknown | 3 mg | Oral |
| Subject | NH102 | Unknown | 10 mg | Oral |
| Subject | NH102 | Unknown | 15 mg | Oral |
| Subject | NH102 | Unknown | 20 mg | Oral |